Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10

Blood

Volumn 95, Issue 10, 2000, Pages 3162-3167

  Rea, Delphine ^a   Van Kooten, Cees ^a   Van Meijgaarden, Krista E ^a   Ottenhoff, Tom H M ^a   Melief, Cornelis J M ^a   Offringa, Rienk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MIFEPRISTONE;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; HELPER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEROID THERAPY; T LYMPHOCYTE ACTIVATION;

EID: 0034657913     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.10.3162     Document Type: Article

References (38)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:248.
2. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor and downregulated by tumor necrosis factor α. J Exp Med. 1994;179: 1109.
3. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995; 182:389.
4. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263.
5. Cella M, Sheidegger D, Palmer-Lehman K, Lane P, Lanzavechia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184:747.
6. Koch F, Stanzl U, Jennevin P, et al. High levels IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med. 1996;184:741.
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13: 251.
8. Kamanaka M, Yu P, Yasui T, et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 1996;4:275.
9. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD2B signaling through CD40. Science. 1996;273:1862.
10. Mackey MF, Gunn JR, Ting P, et al. Protective immunity induced by tumor vaccines requires interactions between CD40 and its ligand CD154. Cancer Res. 1997;57:2569.
11. Grewal IS, Foellmer HG, Grewal KD, et al. Requirement for CD40 ligand in costimulation induction, T cell activation and experimental allergic encephalomyelitis. Science. 1996;273:1864.
12. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A. 1997;94:8789.
13. Durie FH, Aruffo A, Ledbetter J, et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest. 1994;94:1333.
14. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996; 60:563.
15. Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol. 1995;25:2818.
16. Kitajima T, Ariitzumi K, Bergstresser PR, Takashima A. A novel mechanism of glucocorticoid-induced immune suppression: the inhibition of T cell-mediated terminal maturation of a murine dendritic cell line. J Clin Invest. 1996;98:142.
17. Viera PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol. 1998;161:5245.
18. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180:83.
19. Randolph GC, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 1998;82:480.
20. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183.
21. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from non proliferating progenitors in human blood. J Immunol Methods. 1996;196:121.
22. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods. 1996;196:137.
23. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 1995;182:1265.
24. Geluk A, van Meigaarden KE, Janson AAM, et al. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17 binding motif and enables the design of allele-specific competitor peptides. J Immunol. 1992;149:2864.
25. Engering AJ, Cella M, Fluitsma D, et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol. 1997;27:2412.
26. Tan MCAA, Mommaas AA, Drijfhout JW, et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol. 1997;27:2426.
27. de Saint Vis B, Fugier-Vivier I, Massacrier C, et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol. 1998;160:1666.
28. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol. 1999;162:6473.
29. Blotta MH, Dekruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol. 1997;158:5589.
30. Visser J, van Boxel-Dezaire A, Methrost D, Brunt T, de Kloet ER, Nagelkerken L. Differential regulation of interleukin 10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood. 1998;91:4255.
31. van Kooten C, Banchereau J. Function of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol. 1997;9:330.
32. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283.
33. Auphan N, Dinato JA, Rosette C, Helmberg A, Karin N. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270:286.
34. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM. Regulation of interleukin 12 p40 expression through an NF-kappa B half site. Mol Cell Biol. 1995;15:5258.
35. Yoshimoto T, Nagase H, Ishida T, Inoue J, Nariuchi H. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappaB. Eur J Immunol. 1997;27:3461.
36. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998; 393:474.
37. Bennett SR. Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 1998;393:478.
38. Schoenberger SP, Toes REM, van der Voort EI, Offringa R, Melief CJM. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393:480.